Drug Profile
Clobazam suspension - Advicenne
Alternative Names: ADV-5803; LikozamLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Rosemont Pharmaceuticals Ltd
- Developer Advicenne
- Class Antiepileptic drugs; Anxiolytics; Benzodiazepines
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Epilepsy
Most Recent Events
- 17 Oct 2018 Launched for Epilepsy (Combination therapy, Treatment-experienced) in France (PO) prior October 2018 (Advicenne website, October 2018)